Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
Clinical trial NCT02259868 · COMPLETED
Trial details
- NCT number
- NCT02259868
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2005-09-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.